Pinealon Price Comparison — Compare 10 Vendors

View full research →
NeuroprotectionSafety Rating 6/10

Price Comparison

Compare vendors · per 10mg

10 vendors competing

VendorPrice$ / mgUpdated
Polar Peptides5/10$50.39$2.52Apr 17, 2026Buy →
SomaChems7/10$51.99$64.99−20% · code PEPTIDEPRICES$2.60May 14, 2026Buy →
Modern Aminos9/10$68.00$3.40May 14, 2026Buy →
BioLongevity Labs4/10$69.97$3.50Apr 16, 2026Buy →
CertaPeptides7.5/10$72.78$80.87−10% · code PEPTIDEPRICES$3.64Jun 27, 2026Buy →
Core Peptides5.5/10$75.00$3.75Apr 16, 2026Buy →

Research details

Pinealon — research data

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range5–10 mg SC daily for 10-day cycles, 1–2x/year. Russian peptide protocols often combined with Epithalon and Thymalin.
AdministrationSubcutaneous injection
Safety6/10 · Not FDA-approved
NCAA D1Not listed

Overview

About Pinealon

Mechanism of action

Tripeptide from pineal gland; penetrates BBB; modulates serotonin and melatonin synthesis; antioxidant in brain tissue; neuroprotective; regulates circadian neurochemistry.

Safety profile

Very well-tolerated. Minimal reported side effects. Limited but positive Russian clinical data. · Russian bioregulator peptide; short tripeptide; no reported adverse events; limited but clean data

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Pinealon

Research

Studies & key findings

  • Pinealon (Glu-Asp-Arg / EDR) is a synthetic tripeptide bioregulator from the Russian Khavinson 'short peptide bioregulator' tradition, studied for neuroprotection and cognition.
  • The hallmark mechanistic claim of this family — that the peptide directly binds DNA to regulate gene expression — is not well established in mainstream literature and should be treated cautiously.

3 peer-reviewed sources cited — clinical, preclinical, and regulatory.

Read full research →
Failed to fetch